Langerhans Cells Suppress Contact Hypersensitivity Responses Via Cognate CD4 Interaction and Langerhans Cell-Derived IL-101

Mice lacking epidermal Langerhans cells (LC) develop exaggerated contact-hypersensitivity (CHS) responses due to the absence of LC during sensitization/initiation. Examination of T cell responses reveals that the absence of LC leads to increased numbers of hapten-specific CD4 and CD8 T cells but does not alter cytokine expression or development of T regulatory cells. CHS responses and Ag-specific T cells are increased in mice in which MHC class II is ablated specifically in LC suggesting that direct cognate interaction between LC and CD4 cells is required for suppression. LC-derived IL-10 is also required for optimal inhibition of CHS. Both LC-derived IL-10-mediated suppression and full LC activation require LC expression of MHC class II. These data support a model in which cognate interaction of LC with CD4 T cells enables LC to inhibit expansion of Ag-specific responses via elaboration of IL-10.

[1]  L. Bockenstedt,et al.  Langerhans Cell Deficiency Impairs Ixodes scapularis Suppression of Th1 Responses in Mice , 2009, Infection and Immunity.

[2]  Clare L. Bennett,et al.  Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions , 2009, Proceedings of the National Academy of Sciences.

[3]  K. Kabashima,et al.  IL-10-producing Langerhans cells and regulatory T cells are responsible for depressed contact hypersensitivity in grafted skin. , 2009, The Journal of investigative dermatology.

[4]  F. Ginhoux,et al.  Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells , 2008, Nature Reviews Immunology.

[5]  A. Kissenpfennig,et al.  Insights into Langerhans cell function from Langerhans cell ablation models , 2008, European journal of immunology.

[6]  M. Shlomchik,et al.  Langerhans cells are not required for efficient skin graft rejection. , 2008, The Journal of investigative dermatology.

[7]  D. Campbell,et al.  Foxp3+ regulatory T cells maintain immune homeostasis in the skin , 2008, The Journal of experimental medicine.

[8]  E. Devilard,et al.  The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells , 2007, The Journal of experimental medicine.

[9]  K. Hogquist,et al.  Identification of a novel population of Langerin+ dendritic cells , 2007, The Journal of experimental medicine.

[10]  F. Ginhoux,et al.  Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state , 2007, The Journal of experimental medicine.

[11]  Clare L. Bennett,et al.  Langerhans Cells Are Required for Efficient Presentation of Topically Applied Hapten to T Cells1 , 2007, The Journal of Immunology.

[12]  R. Flavell,et al.  Autocrine/paracrine TGFβ1 is required for the development of epidermal Langerhans cells , 2007, The Journal of experimental medicine.

[13]  A. Rudensky,et al.  Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease , 2007, The Journal of experimental medicine.

[14]  J. Penninger,et al.  Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells , 2006, Nature Medicine.

[15]  C. Caux,et al.  Human Langerhans Cells Express a Specific TLR Profile and Differentially Respond to Viruses and Gram-Positive Bacteria1 , 2006, The Journal of Immunology.

[16]  C. Elmets,et al.  CD8+ IL-17-Producing T Cells Are Important in Effector Functions for the Elicitation of Contact Hypersensitivity Responses1 , 2006, The Journal of Immunology.

[17]  A. Enk,et al.  CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue , 2006, European journal of immunology.

[18]  N. Romani,et al.  Epidermal Langerhans cells--changing views on their function in vivo. , 2006, Immunology letters.

[19]  K. Miyake,et al.  Conditional Ablation of MHC-II Suggests an Indirect Role for MHC-II in Regulatory CD4 T Cell Maintenance1 , 2006, The Journal of Immunology.

[20]  A. Thomson,et al.  CD4+ T Cell Responses Elicited by Different Subsets of Human Skin Migratory Dendritic Cells1 , 2005, The Journal of Immunology.

[21]  M. Shlomchik,et al.  Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. , 2005, Immunity.

[22]  N. Romani,et al.  Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. , 2005, The Journal of investigative dermatology.

[23]  J. Buer,et al.  In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity , 2005, Gene Therapy.

[24]  Clare L. Bennett,et al.  Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity , 2005, The Journal of cell biology.

[25]  P. Perrin,et al.  Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. , 2005, Immunity.

[26]  K. Rajewsky,et al.  T Cell–specific Inactivation of the Interleukin 10 Gene in Mice Results in Enhanced T Cell Responses but Normal Innate Responses to Lipopolysaccharide or Skin Irritation , 2004, The Journal of experimental medicine.

[27]  D. Belsito,et al.  Quality of life of patients with allergic contact dermatitis: an exploratory analysis by gender, ethnicity, age, and occupation. , 2004, Dermatitis : contact, atopic, occupational, drug.

[28]  D. von Bubnoff,et al.  Human epidermal langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. , 2004, The Journal of investigative dermatology.

[29]  R. Fairchild,et al.  CD4+ T Cells Regulate CD8+ T Cell-Mediated Cutaneous Immune Responses by Restricting Effector T Cell Development through a Fas Ligand-Dependent Mechanism 1 , 2004, The Journal of Immunology.

[30]  J. Nicolas,et al.  Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. , 2003, Blood.

[31]  A. Mamelak,et al.  Cytokine knockouts in contact hypersensitivity research. , 2003, Cytokine & growth factor reviews.

[32]  P. Marrack,et al.  Control of T cell viability. , 2003, Annual review of immunology.

[33]  I. Homma,et al.  Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. , 2002, Immunity.

[34]  D. Sauder,et al.  Contact hypersensitivity: the mechanism of immune responses and T cell balance. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[35]  M. Mattei,et al.  Identification of Mouse Langerin/CD207 in Langerhans Cells and Some Dendritic Cells of Lymphoid Tissues1 , 2002, The Journal of Immunology.

[36]  A. Shibaki,et al.  Activation through CD40 ligation induces functional Fas ligand expression by Langerhans cells , 2001, European journal of immunology.

[37]  C. Benoist,et al.  The Dendritic Cell Populations of Mouse Lymph Nodes1 , 2001, The Journal of Immunology.

[38]  T. Mak,et al.  CD4+ Th1 and CD8+ Type 1 Cytotoxic T Cells Both Play a Crucial Role in the Full Development of Contact Hypersensitivity1 , 2000, The Journal of Immunology.

[39]  M. Hahne,et al.  Cytotoxicity Is Mandatory for CD8+ T Cell–mediated Contact Hypersensitivity , 1999, The Journal of experimental medicine.

[40]  P. Amerio,et al.  Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. , 1999, Journal of immunology.

[41]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[42]  H. Nomiyama,et al.  Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7* , 1997, The Journal of Biological Chemistry.

[43]  A. Lanzavecchia,et al.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.

[44]  L. Turka,et al.  Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand. , 1996, Journal of immunology.

[45]  R. Fairchild,et al.  T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells , 1996, The Journal of experimental medicine.

[46]  V. Maino,et al.  Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations , 1995, The Journal of experimental medicine.

[47]  J. Revillard,et al.  Major histocompatibility complex class I‐restricted CD8+ T cells and class II‐restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene , 1995, European journal of immunology.

[48]  R. Tigelaar,et al.  Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. , 1990, Journal of immunology.

[49]  S. Jonjić,et al.  Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.

[50]  A. Thomson,et al.  CD4 T Cell Responses Elicited by Different Subsets of Human Skin Migratory Dendritic Cells , 2005 .

[51]  R. Fairchild,et al.  Regulatory role of CD4+ T cells during the development of contact hypersensitivity responses , 2001, Immunologic research.

[52]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.